Abstract Introduction: Cancer therapy seems to be, according to the latest findings, a combination of direct tumor cytotoxicity and the reaction of host immune system, which should become activated to successfully treat neoplastic disease. Monitoring time-dependent changes in composition of tumor infiltrating population of immunocompetent cells during the treatment could help to optimize therapeutic protocols and dosage. Water soluble polymeric conjugates based on N-(2-hydroxypropyl)-methacrylamide (HPMA) bearing anticancer drug doxorubicin bound through amide (DOX-HPMA-AM)) or hydrazone bond (DOX-HPMA-HYD) minimize unwanted side effects of conventional chemotherapy and thus enables much more aggressive treatment with very promising results. To analyze changes in tumor microenvironment during the treatment with such polymeric conjugates, we have used fine needle aspiration biopsy (FNAB). This is a commonly used clinical method to acquire samples from the body with minimal influence to tissues. It seems to be an ideal tool for gaining cell material repeatedly from one experimental animal during the treatment with simultaneous possibility to evaluate tumor growth and efficacy of used therapeutic protocol. Materials and Methods: C57BL/6 mice bearing EL4 T-lymphoma stably expressing Enhanced Green Fluorescent Protein (EL4-EGFP+) were treated with DOX-HPMA-AM, DOX-HPMA-HYD or free doxorubicin. FNAB was applied to isolate samples from EL4-EGFP+ tumors from mice treated with different drugs. All samples were stained with specific fluorescently labeled antibodies (CD3, CD4, CD8, CD45), analyzed by flow cytometry, and verified with the samples obtained from the tumor by excision. Also the tumor progression and survival of mice after FNAB were observed regular time distances. Results: The data obtained by FNAB or standard excision are comparable. Moreover, cell populations gained by FNAB method are more properly separated and contaminated with less debris. FNAB influences neither the tumor progression nor survival of experimental animals. Our data show that the number of tumor-infiltrating CD4 and CD8 lymphocytes increasing rapidly on third day after treatment with DOX-HPMA-AM and DOX-HPMA-HYD, while this treatment leads to complete recovery of neoplasma in all experimental animals. Contrary to this, free doxorubicin has no influence on composition of immunocompetent cells in tumor microenvironment and also no animal was able to recover from neoplastic disease. This fact suggests that both cytotoxic and immunomobilizing effect participate on tumor regression after treatment with HPMA conjugates. Citation Information: Mol Cancer Ther 2009;8(12 Suppl):C241.